Table:
begin	end	state
1	28	signal peptide
29	35	non-cytoplasmic
36	55	transmembrane
56	87	cytoplasmic
88	111	transmembrane
112	116	non-cytoplasmic
117	139	transmembrane
140	159	cytoplasmic
160	183	transmembrane
184	190	non-cytoplasmic
191	209	transmembrane
210	220	cytoplasmic
221	240	transmembrane
241	254	non-cytoplasmic
255	276	transmembrane
277	284	cytoplasmic
285	305	transmembrane
306	324	non-cytoplasmic
325	345	transmembrane
346	365	cytoplasmic
366	391	transmembrane
392	464	non-cytoplasmic
465	485	transmembrane
486	508	cytoplasmic
509	529	transmembrane
530	541	non-cytoplasmic
542	566	transmembrane
567	572	cytoplasmic
573	593	transmembrane
594	641	non-cytoplasmic
642	664	transmembrane
665	688	cytoplasmic

Input:
>AZOBR_RS18105
MPRILNHAPWLVLAVLGAFALGTVALARGETINALWLVVAAVCTYLVSYRYYSLFIATRV
MRLDPARPTPAMRHNDGLDYVPTNQYVLFGHHFAAIAGAGPLVGPVLAAQMGYLPGMLWI
LAGVVVAGAVQDFMILFVSMRRDGRSLGELIKAELGDIPGVIALFGTFMIMVIILAVLAL
VVVKALTNSPWGFFTVAATVPIALFMGIYMRFLRPGRIGEISIIGFFLLIAAILLGGQVA
QSETWAPVFTLTGVQITWILIGYGFVASVLPVWLLLAPRDYLSTFLKVGTIVMLALCILL
VAPPMKMPSVTRFIDGTGPVWSGSLFPFLFITIACGAVSGFHALISSGTTPKMVENELHT
RFIGYGGMLTESFVAVMALVAASCIEPGIYFAMNSPPALLGTTAESAAQVINNWGFVITP
EMITQTAQDVGEVSILSRAGGAPTLAVGMAQIFSELFGGKGMMAFWYHFAILFEALFILT
AVDAGTRAGRFMLQDLLGVFFKPLQRTASWAGNLIATGLCVAAWGYILYQGVVDPLGGIN
TFWPLFGISNQMLAGIALILATVVLFRMKRERYAWVTMVPAAWLLICTLTAGVQKVFHSN
PAIGFLAHAERFSTAANEGRLLAPATSMEQMRQVIFNDYLDAALASLFVLVVLAVLVFGV
LSCLKALRSDRPTTREIPTGGATARAGD

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server